Stem Cell Theranostics Explained

Stem Cell Theranostics
Type:	Private
Location City:	Redwood City, California
Location Country:	United States
Industry:	Biotechnology

Stem Cell Theranostics is a privately held biotech company based out of Redwood City, California that provides drug companies with a method to more accurately predict cardiotoxicity and cardiovascular drug efficacy.^[1]

History

Stem Cell Theranostics was one of the first med tech startup to come out of the StartX incubator program. The company uses technology developed at Stanford,^{[2] [3]} to create a "clinical trial in a dish" drug screening platform, which reduces the risk of drug development.^[4] The company currently works with drug discovery and biotechnology companies to use patient-specific induced pluripotent stem cells for development of novel therapeutics.^[5]

Notes and References

1. Web site: Merck and J&J back StartX; "clinical-trial-in-a-dish" biotech wows at Demo Day. Deanna Pogorelc. MedCity News. 11 November 2014.
2. Web site: Scientists show that lab-made heart cells can be ideal model for disease research, drug testing. Krista Conger. News Center. 11 November 2014.
3. Web site: Researchers use stem cells to pinpoint cause of common type of sudden cardiac death. Krista Conger. News Center. 11 November 2014.
4. Web site: Stem Cell Theranostics' clinical trial in a dish. 29 March 2013. Silicon Valley Business Journal. 11 November 2014.
5. Web site: The Experiment Begins: Y Combinator Admits First Biotech Startups. Xconomy. 11 November 2014.